(Reuters) -Novo Nordisk said on Monday the European drugs regulator has adopted a positive opinion for an update of the Ozempic label to include peripheral artery disease.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shinjini Ganguli)
Brought to you by www.srnnews.com
